Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: Consequences of recombinant feline interferon-ω administration

Veterinary Immunology and Immunopathology

Volumn 118, Issue 1-2, 2007, Pages 68-74

  Paltrinieri, Saverio ^a   Crippa, Alessia ^a   Comerio, Teodora ^b   Angioletti, Andrea ^b   Roccabianca, Paola ^a  

^a Dipartimento di Patologia Animale   (Italy)

^b Ambulatorio Veterinario Anubi   (Italy)

Author keywords

AGP; Electrophoresis; Feline panleukopenia; Immunoglobulin; Interferon ; Parvovirus

Indexed keywords

ALPHA GLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; OROSOMUCOID; RECOMBINANT INTERFERON; RECOMBINANT INTERFERON OMEGA; UNCLASSIFIED DRUG; VIRBAGEN OMEGA;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CAT; COMPARATIVE STUDY; CONTROLLED STUDY; FELINE PANLEUKOPENIA VIRUS; IMMUNE SYSTEM; IMMUNITY; INFLAMMATION; KITTEN; NONHUMAN; PARVOVIRUS INFECTION; POLLUTION; PROPHYLAXIS; SURVIVAL; SURVIVAL RATE;

ANIMALS; CAT DISEASES; CATS; DISEASE OUTBREAKS; INFLAMMATION; INTERFERON TYPE I; PARVOVIRIDAE INFECTIONS; RECOMBINANT PROTEINS;

FELIDAE; FELINE PARVOVIRUS; PARVOVIRUS;

EID: 34250813705     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.04.007     Document Type: Article

References (21)

1. Bohem U., Klamp T., Groot M., and Howard J.C. Cellular responses to interferon-gamma. Ann. Rev. Immunol. 15 (1997) 749-795
2. De Mari K., Maynard L., Eun H.M., and Lebreux B. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial. Vet. Rec. 152 (2003) 105-108
3. De Mari K., Maynard L., Sanquer A., Lebreux B., and Eun H.M. Therapeutic effect of recombinant feline interferon-omega on FeLV-infected and FeLV/FIV-coinfected symptomatic cats. J. Vet. Int. Med. 18 (2004) 477-482
4. Ishida T., Shibanai A., Tanaka S., Uchida K., and Mochizuki M. Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis. J. Fel. Med. Surg. 6 (2004) 107-109
5. Ishiwata K., Minagawa T., and KAjimoto T. Clinical effects of the recombinant feline interferon-ω on experimental parvovirus infection in Beagle dogs. J. Vet. Med. Sci. 60 (1998) 911-917
6. 1-acid glycoprotein, haptoglobin, and C-reactive protein in feline sera due to induced inflammation and surgery. Vet. Immunol. Immunopathol. 68 (1999) 91-98
7. Martin V., Najbar W., Gueguen S., Grousson D., Eun H.M., Lebreux B., and Aubert A. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet. Microbiol. 89 (2002) 115-127
8. Mihaljevic S.Y. First clinical experiences with omega-interferon in the treatment of chronic gingivitis-stomatitis-oropharyngitis of cats. Der Prakt. Tierarzt. 84 (2003) 350-361
9. Minagawa T., Ishiwata K., and Kajimoto T. Feline interferon-ω treatment on canine parvovirus infection. Vet. Microbiol. 69 (1999) 51-53
10. Mochizuki M., Nakatani H., and Yoshida M. Inibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet. Microbiol. 39 (1994) 145-152
11. Mond J.J., Carman J., Sarma C., Ohara J., and Finkelman F.D. Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells. J. Immunol. 137 (1986) 3534-3537
12. Müller D. Interferon therapy in dogs and cats. Kleintiermedizin 8 (2002) 334-337
13. Pollock R.V., and Carmichael L.E. Maternally derived immunity to canine parvovirus infection: transfer, decline and interference with vaccination. J. Am. Vet. Med. Assoc. 180 (1982) 37-42
14. Stark G.R., Kerr I.M., Williams B.R.G., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Ann. Rev. Biochem. 67 (1998) 227-264
15. Tilg H. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 112 (1997) 1017-1021
16. Truyen U., Blewaska S., and Schultheiss U. A study of the antiviral activity of interferon-omega (IFN-ω) against selected canine and feline viruses. J. Mod. Vet. Med. 10 (2002) 862-864
17. Uchino T. Future prospect of feline interferon in prevention of viral disorders. Preventive medicine for dogs and cats. J. Vet. Med. 48 (1995) 663-666
18. Ueda Y., Sakurai T., and Yanai A. Homogeneous production of feline interferon in silkworm by replacing single amino acid code in signal peptide region in recombinant baculovirus and characterization of the product. J. Vet. Med. Sci. 55 (1993) 251-258
19. Ueda Y., Sakurai T., Kasama K., Satoh Y., Atsumi K., Hanawa S., Uchino T., and Yanai A. Pharmacokinetic properties of recombinant feline interferon and its stimulatory effect on 2′, 5′-oligoadenylate synthetase activity in the cat. J. Vet. Med. Sci. 55 (1993) 1-6
20. Wonderling R., Powell T., Baldwin S., Morales T., Snyder S., Keiser K., Hunter S., Best E., McDermott M.J., and Milhausen M. Cloning, expression, purification and biological activity of five feline type I interferons. Vet. Immunol. Immunopathol. 89 (2002) 13-27
21. Zeidner N.S., Myles M.H., Mathiason-Dubard C.K., Dreitz M.J., Mullins J.I., and Hoover E.A. Alpha interferon (2b) in combinantion with zidovudine for the treatment of presymptomatic feline leukaemia virus-induced immunodeficiency syndrome. Antimicrob. Agents Chemother. 34 (1990) 1749-1756